Allianz Asset Management
LLY icon

Allianz Asset Management’s Eli Lilly LLY Stock Holding History

Allianz Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.9M Buy
72,700
+21,800
+43% +$22.1M 0.07% 251
2025
Q4 		$54.7M Sell
50,900
-12,500
-20% -$12M 0.06% 310
2025
Q3 		$48.4M Sell
63,400
-17,000
-21% -$12.7M 0.05% 344
2025
Q2 		$62.7M Buy
80,400
+4,100
+5% +$3.19M 0.08% 257
2025
Q1 		$63M Buy
76,300
+22,600
+42% +$18.8M 0.08% 240
2024
Q4 		$41.5M Buy
53,700
+5,900
+12% +$4.89M 0.06% 345
2024
Q3 		$42.3M Buy
47,800
+21,400
+81% +$19.2M 0.06% 332
2024
Q2 		$23.9M Buy
26,400
+25,000
+1,786% +$20M 0.04% 436
2024
Q1 		$1.09M Sell
1,400
-35,800
-96% -$25.5M ﹤0.01% 1385
2023
Q4 		$21.7M Sell
37,200
-48,100
-56% -$28.1M 0.04% 441
2023
Q3 		$45.8M Buy
85,300
+28,600
+50% +$14.7M 0.08% 258
2023
Q2 		$26.6M Buy
56,700
+6,700
+13% +$2.81M 0.05% 376
2023
Q1 		$17.2M Buy
50,000
+5,300
+12% +$1.79M 0.03% 529
2022
Q4 		$16.4M Buy
44,700
+12,100
+37% +$4.29M 0.03% 531
2022
Q3 		$10.5M Sell
32,600
-8,200
-20% -$2.6M 0.02% 649
2022
Q2 		$13.2M Buy
40,800
+1,500
+4% +$450K 0.01% 810
2022
Q1 		$11.3M Buy
39,300
+700
+2% +$180K 0.01% 956
2021
Q4 		$10.7M Sell
38,600
-41,100
-52% -$10.4M 0.01% 977
2021
Q3 		$18.4M Buy
79,700
+45,200
+131% +$11.2M 0.01% 774
2021
Q2 		$7.92M Buy
34,500
+4,200
+14% +$844K 0.01% 939
2021
Q1 		$5.66M Buy
+30,300
New +$5.93M 0.01% 1008
2020
Q3 		– Sell
-239,700
Closed -$39.4M – 2159
2020
Q2 		$39.4M Buy
239,700
+94,000
+65% +$14.4M 0.05% 394
2020
Q1 		$20.2M Sell
145,700
-93,900
-39% -$12.9M 0.03% 554
2019
Q4 		$31.5M Buy
239,600
+36,100
+18% +$4.18M 0.03% 586
2019
Q3 		$22.8M Sell
203,500
-108,100
-35% -$12M 0.02% 721
2019
Q2 		$34.5M Buy
311,600
+96,000
+45% +$11.3M 0.03% 572
2019
Q1 		$28M Sell
215,600
-142,700
-40% -$17.4M 0.03% 621
2018
Q4 		$41.5M Sell
358,300
-40,800
-10% -$4.56M 0.05% 421
2018
Q3 		$42.8M Sell
399,100
-75,800
-16% -$7.58M 0.04% 499
2018
Q2 		$40.5M Buy
474,900
+26,700
+6% +$2.19M 0.04% 499
2018
Q1 		$34.7M Sell
448,200
-1,517,500
-77% -$122M 0.03% 585
2017
Q4 		$166M Buy
1,965,700
+88,900
+5% +$7.56M 0.13% 168
2017
Q3 		$161M Buy
1,876,800
+417,600
+29% +$34.3M 0.14% 157
2017
Q2 		$120M Buy
1,459,200
+24,700
+2% +$2.02M 0.12% 201
2017
Q1 		$121M Sell
1,434,500
-185,200
-11% -$14.8M 0.12% 189
2016
Q4 		$119M Buy
1,619,700
+831,100
+105% +$61.9M 0.11% 222
2016
Q3 		$63.3M Buy
788,600
+25,800
+3% +$2.07M 0.06% 354
2016
Q2 		$60.1M Buy
762,800
+263,100
+53% +$19.8M 0.06% 334
2016
Q1 		$36M Buy
499,700
+44,500
+10% +$3.37M 0.04% 497
2015
Q4 		$38.4M Buy
455,200
+143,700
+46% +$11.9M 0.04% 494
2015
Q3 		$26.1M Sell
311,500
-147,700
-32% -$12.5M 0.03% 610
2015
Q2 		$38.3M Buy
459,200
+127,100
+38% +$9.68M 0.04% 528
2015
Q1 		$24.1M Sell
332,100
-64,900
-16% -$4.62M 0.03% 620
2014
Q4 		$27.4M Buy
397,000
+246,000
+163% +$16.6M 0.03% 599
2014
Q3 		$9.79M Buy
+151,000
New +$9.56M 0.01% 845

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Allianz Asset Management's LLY Position: Q1 2026 in Review

Allianz Asset Management increased its Eli Lilly (LLY) stake by 18% in Q1 2026, buying an estimated $78.5M and bringing the position to 504,764 shares worth $464M. The position accounts for 0.49% of the portfolio, ranked #29.

Allianz Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $653M in Q4 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Allianz Asset Management held 504,764 shares of Eli Lilly worth $464M as of Q1 2026.
  • Allianz Asset Management bought 77,425 Eli Lilly shares in Q1 2026, an estimated $78.5M.
  • Eli Lilly made up 0.49% of Allianz Asset Management's portfolio in Q1 2026, its #29 holding.
  • Allianz Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Eli Lilly position peaked at $653M in Q4 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.